Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts.

Fiche publication

Date publication

juin 2023

Journal

Expert review of clinical immunology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FATH Léa

Tous les auteurs :
Carsuzaa F, Fath L, Fieux M, Bartier S, de Bonnecaze G, Rumeau C, Michel J, Papon JF, Alexandru M, Favier V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37327360

Résumé

The introduction of biotherapies has significantly changed the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). These drugs are generally reserved for severe or recurrent CRSwNP. Thus, the concepts of severity of the disease and treatment response must be mastered by otorhinolaryngologists. However, a clear definition of these concepts in CRSwNP is missing.